Aviation Medication Transparency Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This bill requires the Federal Aviation Administration (FAA) to create and maintain a publicly available website listing medications that are considered safe for airmen and air traffic control specialists to be prescribed. The list will be developed in consultation with various stakeholders, including medical organizations and unions, and will include information on medication usage guidelines and ‘Do Not Issue’ medications. The FAA will also update the list annually.
Key provisions
- The FAA must publish a list of medications deemed safe for airmen and air traffic control specialists.
- The list will be available on a publicly accessible FAA website.
- The list will be developed with input from the Aeromedical Innovation and Modernization Working Group and other stakeholders.
- The list must include information on medication usage periods and ‘Do Not Issue’ medications.
- The list must provide contact information for doctors to inquire about medication approvals.
- The list must include information about the conditions medications can treat and the reasons for restrictions.
- The FAA must update the list annually.
Who is affected
- Airmen
- Air Traffic Control Specialists
- Individuals training to become airmen or air traffic control specialists
- Medical providers
- The Federal Aviation Administration
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
6 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours